Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Silverman Joshua Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 4 Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.
Txns: Sold 12,740 shares @ $0.8152, valued at $10.4k
06/09/2023 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $1.66, valued at $332k
05/05/2023 4 Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.
Txns: Sold 11,927 shares @ $0.4874, valued at $5.8k
04/28/2023 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Exercised 6,722 restricted stock units @ $0
03/31/2023 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 20,000 options to buy @ $0.87, valued at $17.4k
02/03/2023 4 Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.
Txns: Sold 7,171 shares @ $0.7123, valued at $5.1k
Granted 197,333 shares @ $0
01/25/2023 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Exercised 2,515 restricted stock units @ $0
12/20/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Sold 19,012 shares @ $1.1719, valued at $22.3k
12/01/2022 4/A Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 42,250 shares @ $0
12/01/2022 4/A Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 75,000 options to buy @ $6.07, valued at $455.3k
11/17/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 144,000 options to buy @ $6.07, valued at $874.1k
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/23/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/23/2022 4/A Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Acquired options to buy @ $0
04/11/2022 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Granted 67,227 restricted stock units @ $0
04/06/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2022 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Granted 25,156 restricted stock units @ $0
11/29/2021 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Bought 6,734 shares @ $6.2991, valued at $42.4k
Bought 3,266 shares @ $7.0937, valued at $23.2k
Bought 5,000 shares @ $7.5543, valued at $37.8k
10/15/2021 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 600,000 restricted stock units @ $0
07/15/2021 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 90,000 shares @ $0
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2021 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 38,325 shares @ $4.94, valued at $189.3k
Exercised 109,500 restricted stock units @ $0
04/09/2021 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $3.18, valued at $159k
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2020 4/A Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.
Txns: Granted 122,547 shares @ $0
12/03/2020 4 Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 100,000 shares @ $0
Disposed/sold 9,375 options to buy @ $19.2, valued at $180k
Disposed/sold 124,275 options to buy @ $10.56, valued at $1.3M
Disposed/sold 10,000 options to buy @ $19.1, valued at $191k
Disposed/sold 167,000 options to buy @ $19.62, valued at $3.3M
Disposed/sold 10,000 options to buy @ $8.912, valued at $89.1k
Disposed/sold 150,000 options to buy @ $3.93, valued at $589.5k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 100,000 options to buy @ $0.972, valued at $97.2k
12/02/2020 4 Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.
Txns: Granted 20,000 shares @ $0
Granted 1,875 options to buy @ $96, valued at $180k
Granted 24,855 options to buy @ $52.8, valued at $1.3M
Granted 2,000 options to buy @ $95.5, valued at $191k
Granted 33,400 options to buy @ $98.1, valued at $3.3M
Granted 2,000 options to buy @ $44.56, valued at $89.1k
Granted 30,000 options to buy @ $19.65, valued at $589.5k
Granted 2,000 options to buy @ $20.3, valued at $40.6k
Granted 2,000 options to buy @ $4.1, valued at $8.2k
Granted 20,000 options to buy @ $4.86, valued at $97.2k
12/01/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2020 4 Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 50,000 shares @ $1.0889, valued at $54.4k
10/19/2020 4 Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 50,000 shares @ $1.0663, valued at $53.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy